Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
| NAV2024-11-12 | Chg.-68.1599 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,262.3301EUR | -2.92% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-11-14 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-10-01 | Prospectus | 2024 | German | 5,957.47 KB |
| 2024-10-01 | Prospectus | 2024 | English | 4,049.59 KB |
| 2024-06-30 | Semi-annual report | 2024 | German | 2,233.87 KB |
| 2024-06-30 | Semi-annual report | 2024 | English | 2,123.71 KB |
| 2024-03-01 | PRIIP Key Information Document | 2024 | German | 269.24 KB |
| 2023-12-31 | Account statment | 2023 | English | 5,416.37 KB |
| 2023-12-31 | Account statment | 2023 | German | 4,732.66 KB |
| 2022-07-02 | Key Investor Information | 2022 | German | 363.91 KB |
